Bupropion Tablets and Sustained-Release Tablets and Setlakin
Determining the interaction of Bupropion Tablets and Sustained-Release Tablets and Setlakin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: bupropion
Brand name: Aplenzin, Buproban, Forfivo XL, Wellbutrin SR, Wellbutrin XL, Zyban, Zyban Advantage Pack, Budeprion XL
Synonyms: Bupropion, BuPROPion
Generic Name: ethinyl estradiol / levonorgestrel
Brand name: Afirmelle, Altavera, Amethia, Amethia Lo, Amethyst, Ashlyna, Aubra, Aubra EQ, Aviane, Ayuna, Balcoltra, Camrese, Camrese Lo, Chateal, Chateal EQ, Daysee, Delyla, Enpresse-28, FaLessa, Falmina, Fayosim, Introvale, Jolessa, Kurvelo, Larissia, Lessina, Levonest, Levora 015/30, Lillow, LoSeasonique, Lutera, Marlissa, Myzilra, Orsythia, Portia-28, Quartette, Quasense, Rivelsa, Seasonique, Setlakin, Simpesse, Sronyx, Trivora, Vienva, Alesse, Enpresse, Levlen, Levora, Lybrel, Nordette, Portia, Tri-Levlen, Triphasil-21, Triphasil-28, Trivora-28, Seasonale, Preven EC, Triphasil
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bupropion Tablets and Sustained-Release Tablets-SetonET
- Bupropion Tablets and Sustained-Release Tablets-SetonET-EC DHA
- Bupropion Tablets and Sustained-Release Tablets-Sevelamer
- Bupropion Tablets and Sustained-Release Tablets-Sevelamer Hydrochloride Tablets
- Bupropion Tablets and Sustained-Release Tablets-Sevelamer Powder Packets
- Bupropion Tablets and Sustained-Release Tablets-Sevelamer Suspension
- Setlakin-Burapren Injection
- Setlakin-Burn-O-Jel Topical application
- Setlakin-Burnamycin Topical application
- Setlakin-Burosumab
- Setlakin-Burosumab-twza
- Setlakin-Burosumab-twza Subcutaneous